Detalhe da pesquisa
1.
Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
Breast Cancer Res Treat
; 167(1): 407, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29071491
2.
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
Breast Cancer Res Treat
; 165(2): 343-353, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28612226
3.
Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC).
Trials
; 18(1): 327, 2017 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28716064